IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $657,811,855 | +10.4% | 14,502,025 | -0.1% | 0.02% | +14.3% |
| Q2 2023 | $595,889,604 | +19.3% | 14,523,266 | +3.9% | 0.01% | +7.7% |
| Q1 2023 | $499,494,734 | -2.4% | 13,975,790 | +3.2% | 0.01% | -7.1% |
| Q4 2022 | $511,658,632 | -9.7% | 13,546,694 | +5.8% | 0.01% | -17.6% |
| Q3 2022 | $566,411,000 | +25.4% | 12,806,023 | +5.0% | 0.02% | +30.8% |
| Q2 2022 | $451,653,000 | +0.8% | 12,200,276 | +0.8% | 0.01% | +18.2% |
| Q1 2022 | $448,148,000 | +22.7% | 12,099,034 | +0.8% | 0.01% | +37.5% |
| Q4 2021 | $365,376,000 | -7.7% | 12,007,076 | +1.8% | 0.01% | -20.0% |
| Q3 2021 | $395,773,000 | -21.6% | 11,800,009 | -6.8% | 0.01% | -23.1% |
| Q2 2021 | $504,841,000 | -10.9% | 12,655,829 | +0.4% | 0.01% | -13.3% |
| Q1 2021 | $566,682,000 | -18.1% | 12,604,149 | +2.9% | 0.02% | -25.0% |
| Q4 2020 | $692,298,000 | +21.7% | 12,244,388 | +2.1% | 0.02% | +5.3% |
| Q3 2020 | $568,926,000 | -21.6% | 11,990,030 | -2.6% | 0.02% | -26.9% |
| Q2 2020 | $725,576,000 | +27.3% | 12,306,251 | +2.1% | 0.03% | +8.3% |
| Q1 2020 | $569,893,000 | -21.2% | 12,053,561 | +0.7% | 0.02% | -4.0% |
| Q4 2019 | $722,890,000 | -1.2% | 11,966,392 | -2.0% | 0.02% | -7.4% |
| Q3 2019 | $731,769,000 | -11.4% | 12,214,475 | -5.0% | 0.03% | -12.9% |
| Q2 2019 | $826,311,000 | -18.4% | 12,856,865 | +3.1% | 0.03% | -22.5% |
| Q1 2019 | $1,012,475,000 | +58.3% | 12,473,515 | +5.4% | 0.04% | +37.9% |
| Q4 2018 | $639,496,000 | +11.8% | 11,829,388 | +6.7% | 0.03% | +31.8% |
| Q3 2018 | $572,089,000 | +25.6% | 11,091,298 | +1.4% | 0.02% | +15.8% |
| Q2 2018 | $455,600,000 | -0.4% | 10,933,528 | +5.4% | 0.02% | -5.0% |
| Q1 2018 | $457,347,000 | -10.0% | 10,375,396 | +2.7% | 0.02% | -9.1% |
| Q4 2017 | $508,343,000 | +0.8% | 10,106,212 | +1.6% | 0.02% | -8.3% |
| Q3 2017 | $504,158,000 | +0.6% | 9,943,951 | +0.9% | 0.02% | -4.0% |
| Q2 2017 | $501,332,000 | +32.1% | 9,855,160 | +4.4% | 0.02% | +25.0% |
| Q1 2017 | $379,399,000 | -12.4% | 9,437,796 | +4.3% | 0.02% | -16.7% |
| Q4 2016 | $433,004,000 | +34.4% | 9,052,966 | +3.0% | 0.02% | +26.3% |
| Q3 2016 | $322,181,000 | +57.3% | 8,793,152 | -0.0% | 0.02% | +46.2% |
| Q2 2016 | $204,831,000 | -40.1% | 8,794,783 | +4.1% | 0.01% | -40.9% |
| Q1 2016 | $342,047,000 | -33.1% | 8,445,611 | +2.4% | 0.02% | -35.3% |
| Q4 2015 | $510,968,000 | – | 8,250,750 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |